Diabetes Care, Vol 20, Issue 10 1512-1517, Copyright © 1997 by American Diabetes Association

ARTICLES

Impact of dosage frequency on patient compliance

AH Paes, A Bakker and CJ Soe-Agnie
Department of Pharmacoepidemiology and Pharmacotherapy, Universiteit Utrecht, The Netherlands.

OBJECTIVE: To evaluate the impact of dosage frequency on the compliance of patients who receive their medicines from community pharmacies. RESEARCH DESIGN AND METHODS: Each month, patients received a supply of their medication in a Medication Event Monitoring Systems container, which registered each opening of the package. At the end of the study, the patients received a short questionnaire. The subjects were 91 diabetic patients using oral antidiabetic agents. Patients taking insulin and those who were unable to collect their medicines from the pharmacy were excluded from the study. Compliance was defined as the percentage of doses taken during the observation period. Another parameter used was compliance with the prescribed regimen, defined as the percentage of days in which the number of tablets were taken as prescribed. As a last parameter, compliance with the prescribed dose intervals was used. RESULTS: Compliance is influenced by the frequency of doses. The compliance for this group of patients is 74.8%, with an average of 79% in the case of a dose once daily and 38% in the case of a dose three times daily. The predominant type of noncompliance in all groups was dose omissions. However, more than one-third of the patients used more doses than prescribed. Overconsumption is a frequently made mistake by patients on a one-dose daily schedule. CONCLUSIONS: The reduction of dose frequency may decrease total noncompliance, but at the same time, it increases the risk of overconsumption. Reducing the frequency does not automatically result in a better therapeutic schedule. The choice of once or twice daily should depend on the therapeutic range of the drug.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				P. S. Odegard and S. L. Gray Barriers to Medication Adherence in Poorly Controlled Diabetes Mellitus The Diabetes Educator, July 1, 2008; 34(4): 692 - 697. [Abstract] [Full Text] [PDF]

				P. S. Odegard and K. Capoccia Medication Taking and Diabetes: A Systematic Review of the Literature The Diabetes Educator, November 1, 2007; 33(6): 1014 - 1029. [Abstract] [Full Text] [PDF]

				W. Polonsky Psychological Insulin Resistance: The Patient Perspective The Diabetes Educator, July 1, 2007; 33(Supplement_7): 241S - 244S. [Full Text] [PDF]

				A. M. Delamater Improving Patient Adherence Clin. Diabetes, April 1, 2006; 24(2): 71 - 77. [Abstract] [Full Text] [PDF]

				I. D Kalsekar, S. S Madhavan, M. M Amonkar, E. H Makela, V. G Scott, S. M Douglas, and B. L M. Elswick Depression in Patients with Type 2 Diabetes: Impact on Adherence to Oral Hypoglycemic Agents Ann. Pharmacother., April 1, 2006; 40(4): 605 - 611. [Abstract] [Full Text] [PDF]

				S. B. Leichter Making Outpatient Care of Diabetes More Efficient: Analyzing Noncompliance Clin. Diabetes, October 1, 2005; 23(4): 187 - 190. [Full Text] [PDF]

				L. Osterberg and T. Blaschke Adherence to Medication N. Engl. J. Med., August 4, 2005; 353(5): 487 - 497. [Full Text] [PDF]

				A. M. Kilbourne, C. B. Good, S. M. Sereika, A. C. Justice, and M. J. Fine Algorithm for assessing patients' adherence to oral hypoglycemic medication Am. J. Health Syst. Pharm., January 15, 2005; 62(2): 198 - 204. [Full Text] [PDF]

				J. George, Y.-T. Phun, M. J Bailey, D. C. Kong, and K. Stewart Development and Validation of the Medication Regimen Complexity Index Ann. Pharmacother., September 1, 2004; 38(9): 1369 - 1376. [Abstract] [Full Text] [PDF]

				J. Davidson and H. Howlett New prolonged-release metformin improves gastrointestinal tolerability The British Journal of Diabetes & Vascular Disease, July 1, 2004; 4(4): 273 - 277. [Abstract] [PDF]

				J. A. Cramer A Systematic Review of Adherence With Medications for Diabetes Diabetes Care, May 1, 2004; 27(5): 1218 - 1224. [Abstract] [Full Text] [PDF]

				U. A Shukla, E. M Chi, and K.-H. Lehr Glimepiride Pharmacokinetics in Obese Versus Non-Obese Diabetic Patients Ann. Pharmacother., January 1, 2004; 38(1): 30 - 35. [Abstract] [Full Text] [PDF]

				S. B. Leichter and S. Thomas Combination Medications in Diabetes Care: An Opportunity That Merits More Attention Clin. Diabetes, October 1, 2003; 21(4): 175 - 178. [Full Text] [PDF]

				A. D. Morris Addressing Dosing Frequency in Diabetes: A Simple Approach to Improving Adherence to Therapy and Clinical Outcomes The Diabetes Educator, May 1, 2003; 29(3): 440 - 453. [PDF]

				R. W. Grant, N. G. Devita, D. E. Singer, and J. B. Meigs Polypharmacy and Medication Adherence in Patients With Type 2 Diabetes Diabetes Care, May 1, 2003; 26(5): 1408 - 1412. [Abstract] [Full Text] [PDF]

				A. Emslie-Smith, J. Dowall, and A. Morris The problem of polypharmacy in type 2 diabetes The British Journal of Diabetes & Vascular Disease, January 1, 2003; 3(1): 54 - 56. [Abstract] [PDF]

				C. A Reasner and B. Goke Overcoming the barriers to effective glycaemic control for type 2 diabetes The British Journal of Diabetes & Vascular Disease, July 1, 2002; 2(4): 290 - 295. [PDF]

				S. J. Boccuzzi, J. Wogen, J. Fox, J. C.Y. Sung, A. B. Shah, and J. Kim Utilization of Oral Hypoglycemic Agents in a Drug-Insured U.S. Population Diabetes Care, August 1, 2001; 24(8): 1411 - 1415. [Abstract] [Full Text] [PDF]

				J. Baillargeon, A. D. Linton, S. A. Black, S. Zepeda, and J. J. Grady Medication Prescribing and Adherence Patterns Among Prison Inmates With Diabetes Mellitus Journal of Correctional Health Care, April 1, 2001; 8(1): 37 - 53. [Abstract] [PDF]

				J. H. Scarpello Review: Optimal dosing strategies for maximising the clinical response to metformin in type 2 diabetes The British Journal of Diabetes & Vascular Disease, January 1, 2001; 1(1): 28 - 36. [Abstract] [PDF]